Journal article
Impact of Antibiotic Administrative Restrictions on Trends in Antibiotic Resistance
Abstract
ContextIn March 2001, in response to concerns about increasing resistance to fluoroquinolone (FQ) antibiotics, the Ontario Drug Benefit (ODB) program limited reimbursement of FQs to ODB beneficiaries defined as high risk or in whom other therapies are not tolerated.ObjectiveTo analyze the impact of the limited use (LU) policy changes on antibiotic resistance rates in Ontario, focussing on community-acquired pathogens.DesignOntario data …
Authors
Marshall DA; McGeer A; Gough J; Grootendorst P; Buitendyk M; Simonyi S; Green K; Jaszewski B; MacLeod SM; Low DE
Journal
Canadian Journal of Public Health, Vol. 97, No. 2, pp. 126–131
Publisher
Springer Nature
Publication Date
March 2006
DOI
10.1007/bf03405330
ISSN
0008-4263
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AmoxicillinAnti-Bacterial AgentsCommunity-Acquired InfectionsDrug Resistance, BacterialDrug UtilizationErythromycinFluoroquinolonesHealth PolicyHumansInsurance, Pharmaceutical ServicesOntarioPenicillinsPneumonia, BacterialReimbursement MechanismsStreptococcus pneumoniaeTrimethoprim, Sulfamethoxazole Drug Combination